Oxycodone News and Research

RSS

Novel approach to pain therapy paves way for lower dosage painkillers

For patients managing cancer and other chronic health issues, painkillers such as morphine and Vicodin are often essential for pain relief. The body's natural tendency to develop tolerance to these medications, however, often requires patients to take higher doses - increasing risks of harmful side effects and dependency.

11 Jun 2013

FDA to review QRxPharma's resubmitted MOXDUO NDA in July 2013

QRxPharma Limited announced today the US Food and Drug Administration has set 17 July 2013 as the date of the Advisory Committee meeting to consider the Company's resubmitted MOXDUO New Drug Application.

18 May 2013

Regularly taking prescription painkillers is associated with higher risk of ED in men

Regularly taking prescription painkillers, also known as opioids, is associated with a higher risk of erectile dysfunction (ED) in men, according to a study published online today in the journal Spine.

17 May 2013

DURECT: Pfizer provides update on investigational drug Remoxy

DURECT Corporation today announced that Pfizer has provided an update on Remoxy as part of their Form 10-Q filing.

10 May 2013

Sucampo's supplemental new drug application for AMITIZA gets FDA approval

Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc. announced today that the United States Food and Drug Administration has approved Sucampo's supplemental new drug application for AMITIZA (lubiprostone) (24 mcg twice daily) as the first and only oral medication for the treatment of opioid-induced constipation in adult patients with chronic, non-cancer pain.

24 Apr 2013

Neura Therapeutik plans to speed up development of abuse-deterrent, generic extended-release opioids

Neura Therapeutik announced today that they will be accelerating the development of their abuse-deterrent brand and generic extended-release opioids.

19 Apr 2013

Updated labeling for Purdue Pharma's reformulated OxyContin tablets gets FDA approval

The U.S. Food and Drug Administration today approved updated labeling for Purdue Pharma L.P.'s reformulated OxyContin (oxycodone hydrochloride controlled-release) tablets.

17 Apr 2013

Growth in opioid use prompts safety concerns

Prescriptions for opioid drugs have increased significantly in Germany over the past decade, a survey of insurance data has found.

20 Feb 2013

Scientists demonstrate new approach for quickly assembling drug-like compounds

A team of scientists anchored at Yale University has demonstrated a new, highly versatile approach for quickly assembling drug-like compounds, establishing a broad new route to drug discovery and medical treatment.

11 Feb 2013

Low testosterone levels occur more often among men on long-acting opioids

Low testosterone levels occur five times more often among men who take long-acting instead of short-acting opioids for chronic pain, according to a new Kaiser Permanente study published in The Clinical Journal of Pain.

2 Feb 2013

Study: OEND effectively addresses epidemic of fatal opioid overdose

In a study of communities in Massachusetts with high numbers of opioid overdose deaths, the implementation of overdose education and naloxone distribution (OEND) was associated with a significant reduction in opioid overdose death rates.

2 Feb 2013

QrxPharma to resubmit MOXDUO NDA with FDA

QRxPharma Limited announced today that the steps necessary for approval of immediate release MOXDUO have been clarified with the United States Food and Drug Administration (FDA).

17 Jan 2013

State roundup: Maine hospitals fighting for timely Medicaid payments

New York police plan to distribute "bait bottles" of fake pain-killers equipped with invisible GPS devices in a drive to combat the scourge of pharmacy robberies by addicts and sellers looking for oxycodone tablets, which can fetch more than $80 per pill on the street.

17 Jan 2013

First Edition: January 16, 2013

Today's headlines include reports examining how mental health issues play a role in efforts to curb gun violence and expand gun control efforts.

16 Jan 2013

Roundup: Medicaid waiver challenges in Texas; Detailing Sandy's impact on NYC's mental care

By 2012's end, health care providers across Texas will have submitted proposals to state leaders to transform the way they care for the poor and uninsured. They have been spurred by a Medicaid waiver Texas officials sought and received in 2011 from the federal government, one that ties financing to cooperation, cost efficiency and better patient outcomes.

2 Jan 2013

Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

Janssen-Cilag International NV (Janssen) announced today that the Committee for Medical Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending approval of the oral, once-daily medication ZYTIGA for use in combination with prednisone or prednisolone in the treatment of metastatic castration-resistant prostate cancer (mCRPC), in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.

19 Nov 2012

Study examines public health impact of tamper resistant extended-release oxycodone

This is the first epidemiological study to examine the public health impact of a tamper resistant extended-release oxycodone (ORF). ER oxycodone was reformulated with physicochemical barriers to crushing and dissolving intended to reduce abuse through non-oral routes of administration.

16 Nov 2012